REAL-WORLD COMPARISON OF HEALTHCARE COSTS AMONG PATIENTS WITH TYPE 2 DIABETES TREATED WITH DULAGLUTIDE VS. LIRAGLUTIDE IN THE UNITED STATES

被引：0
|
作者：
Mody, R. [1 ]
Huang, Q. [2 ]
Yu, M. [3 ]
Patel, H. [1 ]
Zhao, R. [2 ]
Grabner, M. [2 ]
Lando, Fernandez L. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] HealthCore Inc, Wilmington, DE USA
[3] Eli Lilly & Co, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.520
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB89
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [31] Metformin dosage patterns in type 2 diabetes patients in a real-world setting in the United States
    Mahabaleshwarkar, Rohan
    DeSantis, Andrea
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 172
  • [32] Comparison of real-world direct healthcare costs for metastatic colorectal cancer patients treated with cetuximab vs. bevacizumab as first-line therapy.
    Johnston, Stephen
    Ogale, Sarika
    Riehle, Ellen
    Varker, Helen
    Juneau, Paul
    Wilson, Kathleen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax
    Rogers, Kerry A.
    Emond, Bruno
    Manceur, Ameur M.
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (08) : 1409 - 1420
  • [34] Real-world clinical outcomes and healthcare costs in patients with Crohn's disease treated with vedolizumab versus ustekinumab in the United States
    Chiorean, Michael
    Jiang, Jeanne
    Candela, Ninfa
    Chen, Grace
    Romdhani, Hela
    Latremouille-Viau, Dominick
    Shi, Sherry
    Bungay, Rebecca
    Guerin, Annie
    Fan, Tao
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (05) : 877 - 885
  • [35] Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States
    Durden, Emily
    Lenhart, Greg
    Lopez-Gonzalez, Lorena
    Hammer, Mette
    Langer, Jakob
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (04) : 403 - 413
  • [36] The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in type 2 diabetes patients (TROPHIES): resource use and costs of treatment in clinical practice in France, Germany, and Italy
    Barrett, Annabel
    Boye, Kristina S.
    Garcia-Perez, Luis-Emilio
    Giorgino, Francesco
    Guerci, Bruno
    Fuchtenbusch, Martin
    Yu, Maria
    Sapin, Helene
    Dib, Anne
    Heitmann, Elke
    Federici, Marco Orsini
    Lebrec, Jeremie
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 866 - 879
  • [37] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION IN URTICARIA PATIENTS NEWLY TREATED WITH OMALIZUMAB IN THE UNITED STATES
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V. J.
    Stephenson, J. J.
    Ortiz, B.
    Paknis, B.
    Bernstein, J. A.
    Beck, L. A.
    VALUE IN HEALTH, 2017, 20 (05) : A161 - A161
  • [38] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Twelve-Month Data Analysis
    Guerci, Bruno
    Giorgino, Francesco
    Garcia, Luis-Emilio
    Boye, Kristina
    Norrbacka, Kirsi
    Sapin, Helene
    Heitmann, Elke
    Lebrec, Jeremie
    Dib, Anne
    Federici, Marco O. Orsini
    DIABETES, 2021, 70
  • [39] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE AND LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): PATIENT-REPORTED OUTCOMES AT BASELINE
    Boye, K.
    Garcia-Perez, L. E.
    Sapin, H.
    Rosilio, M.
    Federici, Orsini M.
    Heitmann, E.
    Jung, H.
    Gentilella, R.
    Aigner, U.
    Guerci, B.
    Giorgino, F.
    Norrbacka, K.
    VALUE IN HEALTH, 2019, 22 : S593 - S593
  • [40] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
    Boye, Kristina S.
    Sapin, Helene
    Garcia-Perez, Luis-Emilio
    Rosilio, Myriam
    Orsini Federici, Marco
    Heitmann, Elke
    Jung, Heike
    Aigner, Ulrich
    Guerci, Bruno
    Giorgino, Francesco
    Norrbacka, Kirsi
    DIABETES THERAPY, 2020, 11 (10) : 2383 - 2399
12345